Parenteral Drug Association
Connecting People, Science and Regulation ®
by: Christoph Bredack, PhD, Genedata
by: Lucia Ceresa
by: Parampal Deol
John MacEwen, Körber Medipak Systems NA Inc
Susanne Keitel, PhD, EDQM
Bei Ma, Pinea Group
Stephan Krause, AstraZeneca, Emanuela Lacana, U.S. FDA, and Rebecca Stauffer, PDA
Marc Baiget Francesch, Tiselab
Rebecca Stauffer, PDA
Tony Cundell, PhD, Microbiological Consulting, and Michael Miller, PhD, Microbiology Consultants
Henry Brush, Zagfen, New England Chapter Member-at-Large
Jackie Veivia-Panter, Legend Biotech
Florian Krickl, Vitronic
James Assini, Sanofi
Jennifer Loughman and Paul Lopolito, STERIS
John Shabushnig, PhD, Insight Pharma Consulting; Markus Lankers, PhD, MIBIC; John Ayres, MD, Pharma Safety Solutions; Roy Cherris, Bridge Associates; Robert Miller, Pfizer; Romain Veillon, GSK Vaccines; and Rick Watson, Merck
Aaron Goerke, PhD, F. Hoffmann-La Roche AG, and Michele D’Alessandro, Merck & Company, Inc.
Kathryn MacDonald, Middlesex Community College
Peter Makowenskyj, G-CON Manufacturing
Brian Hawkins, PhD, Pluristyx, Inc.
Cristiana Campa, GSK, and Michael De Felippis, Eli Lilly and Company
Per Vase, PhD, NNE
Hal Baseman, ValSource
Steven Lynn, Lynn Consulting
Kevin L. Williams, bioMérieux
Ursula Busse, PhD, Novartis
Michael Blackton, Adaptimmune
Magaly E. Aham, Takeda Pharmaceuticals
Brendan Tindall, biomerieux, and Graham Vesey, Regeneus
Bruce Loxley, GSK Vaccines, PDA Singapore Chapter Member-at-Large
Stephenie Overman
Qingyu Zeng, PhD, West Pharmaceutical Services, Inc.
Djikolngar Maouyo, Pyrodex
Robert Guidos, Corning
Karen Walker, Seattle Genetics, and Tia Bush, Amgen
Biny Joseph, Vienni Training and Consulting
Toni Manzano, bigfinite
David Hubmayr, CSL Behring
Walter Alexander
Annette Kirsch, PhD, Merck KGaA
Fatima Hasanain, Polymer Materials Specialist, Nordion (Canada) Inc.
Steven Lynn, Lynn Consulting, LLC
Carina Bronnbauer, PhD, SCHOTT
Jose C. Menezes, PhD, 4Tune Engineering
David Pittman
Lori Richter, ValSource
John Shabushnig, PhD, Insight Pharma Consulting, and Markus Lankers, PhD, Mibic GmbH
Jana Spes, Boston Biomedical, and Wayne Levin, Predictum
Khan Lau, Promedica International
Jaime Cobo, WILCO AG
Aneeta Mathur-Ashton, American University
Melissa Seymour, Biogen, Inc., and Ghada Haddad , Merck & Co./ Merck Sharp & Dohme
Aoife Clancy, Trinity College Dublin
Thomas Beutler, GEA, and Yves Mayeresse, GSK
John Groth, SKAN US
John Dubczak, Charles River Laboratories
Karolina Heed, Hyglos - a bioMérieux company
Heino Prinz, Rommelag
Dalmaso Gilberto, PhD, and Lisa G. Lawson, Particle Measuring Systems
Nic Bowman, Pfizer
Jay Bolden, Eli Lilly and Company, and Ned Mozier, PhD, Pfizer
Lee Leichter, P/L Biomedical
Walid El Azab, STERIS Life Science
Alessandro Morandotti, Ompi
James Tucker, Ecolab Life Sciences
Michael Miller, PhD, Microbiology Consultants
David Hussong, PhD, Eagle Analytical Services, Radhakrishna Tirumalai, PhD, USP, Edward Tidswell, PhD, Merck, and Donald Singer, GSK
Biny Joseph, PDA India Chapter Coordinator
John Shabushnig, PhD, Insight Pharma Consulting; Rick Watson, Merck and Rob Miller, Pfizer
Vladislav Shestakov, Russian State Institute of Drugs and Good Practices, and Elizabeth Meyers, Amgen
Vito Pirrera and John Jordon, Vantage Solutions
Brian J. Hawkins, Alireza Abazari, Aby J. Mathew, BioLife Solutions
Janie (Jahanvi) Miller, PDA
Darryl Peterson, Antares Vision
Rebecca Stauffer and Aneeta Mathur-Ashton, PDA
Oliver Stauffer, PTI
Mark Crawford
Anthony Newcombe, PhD, and Siegfried Schmitt, PhD, PAREXEL
Mckenzie Orchowski, Biologics Consulting
David Chesney, DL Chesney Consulting
Jennifer Farrington, PhD, Associates of Cape Cod, and Friedrich von Wintzingerode, PhD, Roche Diagnostics GmbH
John Shabushnig, PhD, Insight Pharma Consulting, and Markus Lankers, PhD
Stephan Krause, PhD, AstraZeneca Biologics, and Jens Schletter, PhD, Novartis